Cargando…

Treatment and outcomes of anticoagulated geriatric trauma patients with traumatic intracranial hemorrhage after falls

INTRODUCTION: Emergency physicians and trauma surgeons are increasingly confronted with pre-injury direct oral anticoagulants (DOACs). The objective of this study was to assess if pre-injury DOACs, compared to vitamin K antagonists (VKA), or no oral anticoagulants is independently associated with di...

Descripción completa

Detalles Bibliográficos
Autores principales: Nederpelt, Charlie J., Naar, Leon, Meier, Karien, van Wijck, Suzanne F. M., Krijnen, Pieta, Velmahos, George C., Kaafarani, Haytham M. A., Rosenthal, Martin G., Schipper, Inger B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532305/
https://www.ncbi.nlm.nih.gov/pubmed/35267051
http://dx.doi.org/10.1007/s00068-022-01938-7
_version_ 1784802093239894016
author Nederpelt, Charlie J.
Naar, Leon
Meier, Karien
van Wijck, Suzanne F. M.
Krijnen, Pieta
Velmahos, George C.
Kaafarani, Haytham M. A.
Rosenthal, Martin G.
Schipper, Inger B.
author_facet Nederpelt, Charlie J.
Naar, Leon
Meier, Karien
van Wijck, Suzanne F. M.
Krijnen, Pieta
Velmahos, George C.
Kaafarani, Haytham M. A.
Rosenthal, Martin G.
Schipper, Inger B.
author_sort Nederpelt, Charlie J.
collection PubMed
description INTRODUCTION: Emergency physicians and trauma surgeons are increasingly confronted with pre-injury direct oral anticoagulants (DOACs). The objective of this study was to assess if pre-injury DOACs, compared to vitamin K antagonists (VKA), or no oral anticoagulants is independently associated with differences in treatment, mortality and inpatient rehabilitation requirement. METHODS: We performed a review of the prospectively maintained institutional trauma registry at an urban academic level 1 trauma center. We included all geriatric patients (aged ≥ 65 years) with tICH after a fall, admitted between January 2011 and December 2018. Multivariable logistic regression analysis controlling for demographics, comorbidities, vital signs, and tICH types were performed to identify the association between pre-injury anticoagulants and reversal agent use, neurosurgical interventions, inhospital mortality, 3-day mortality, and discharge to inpatient rehabilitation. RESULTS: A total of 1453 tICH patients were included (52 DOAC, 376 VKA, 1025 control). DOAC use was independently associated with lower odds of receiving specific reversal agents [odds ratio (OR) 0.28, 95% confidence interval (CI) 0.15–0.54] than VKA patients. DOAC use was independently associated with requiring neurosurgical intervention (OR 3.14, 95% CI 1.36–7.28). VKA use, but not DOAC use, was independently associated with inhospital mortality, or discharge to hospice care (OR 1.62, 95% CI 1.15–2.27) compared to controls. VKA use was independently associated with higher odds of discharge to inpatient rehabilitation (OR 1.41, 95% CI 1.06–1.87) compared to controls. CONCLUSION: Despite the higher neurosurgical intervention rates, patients with pre-injury DOAC use were associated with comparable rates of mortality and discharge to inpatient rehabilitation as patients without anticoagulation exposure. Future research should focus on risk assessment and stratification of DOAC-exposed trauma patients.
format Online
Article
Text
id pubmed-9532305
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-95323052022-10-06 Treatment and outcomes of anticoagulated geriatric trauma patients with traumatic intracranial hemorrhage after falls Nederpelt, Charlie J. Naar, Leon Meier, Karien van Wijck, Suzanne F. M. Krijnen, Pieta Velmahos, George C. Kaafarani, Haytham M. A. Rosenthal, Martin G. Schipper, Inger B. Eur J Trauma Emerg Surg Original Article INTRODUCTION: Emergency physicians and trauma surgeons are increasingly confronted with pre-injury direct oral anticoagulants (DOACs). The objective of this study was to assess if pre-injury DOACs, compared to vitamin K antagonists (VKA), or no oral anticoagulants is independently associated with differences in treatment, mortality and inpatient rehabilitation requirement. METHODS: We performed a review of the prospectively maintained institutional trauma registry at an urban academic level 1 trauma center. We included all geriatric patients (aged ≥ 65 years) with tICH after a fall, admitted between January 2011 and December 2018. Multivariable logistic regression analysis controlling for demographics, comorbidities, vital signs, and tICH types were performed to identify the association between pre-injury anticoagulants and reversal agent use, neurosurgical interventions, inhospital mortality, 3-day mortality, and discharge to inpatient rehabilitation. RESULTS: A total of 1453 tICH patients were included (52 DOAC, 376 VKA, 1025 control). DOAC use was independently associated with lower odds of receiving specific reversal agents [odds ratio (OR) 0.28, 95% confidence interval (CI) 0.15–0.54] than VKA patients. DOAC use was independently associated with requiring neurosurgical intervention (OR 3.14, 95% CI 1.36–7.28). VKA use, but not DOAC use, was independently associated with inhospital mortality, or discharge to hospice care (OR 1.62, 95% CI 1.15–2.27) compared to controls. VKA use was independently associated with higher odds of discharge to inpatient rehabilitation (OR 1.41, 95% CI 1.06–1.87) compared to controls. CONCLUSION: Despite the higher neurosurgical intervention rates, patients with pre-injury DOAC use were associated with comparable rates of mortality and discharge to inpatient rehabilitation as patients without anticoagulation exposure. Future research should focus on risk assessment and stratification of DOAC-exposed trauma patients. Springer Berlin Heidelberg 2022-03-10 2022 /pmc/articles/PMC9532305/ /pubmed/35267051 http://dx.doi.org/10.1007/s00068-022-01938-7 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Nederpelt, Charlie J.
Naar, Leon
Meier, Karien
van Wijck, Suzanne F. M.
Krijnen, Pieta
Velmahos, George C.
Kaafarani, Haytham M. A.
Rosenthal, Martin G.
Schipper, Inger B.
Treatment and outcomes of anticoagulated geriatric trauma patients with traumatic intracranial hemorrhage after falls
title Treatment and outcomes of anticoagulated geriatric trauma patients with traumatic intracranial hemorrhage after falls
title_full Treatment and outcomes of anticoagulated geriatric trauma patients with traumatic intracranial hemorrhage after falls
title_fullStr Treatment and outcomes of anticoagulated geriatric trauma patients with traumatic intracranial hemorrhage after falls
title_full_unstemmed Treatment and outcomes of anticoagulated geriatric trauma patients with traumatic intracranial hemorrhage after falls
title_short Treatment and outcomes of anticoagulated geriatric trauma patients with traumatic intracranial hemorrhage after falls
title_sort treatment and outcomes of anticoagulated geriatric trauma patients with traumatic intracranial hemorrhage after falls
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532305/
https://www.ncbi.nlm.nih.gov/pubmed/35267051
http://dx.doi.org/10.1007/s00068-022-01938-7
work_keys_str_mv AT nederpeltcharliej treatmentandoutcomesofanticoagulatedgeriatrictraumapatientswithtraumaticintracranialhemorrhageafterfalls
AT naarleon treatmentandoutcomesofanticoagulatedgeriatrictraumapatientswithtraumaticintracranialhemorrhageafterfalls
AT meierkarien treatmentandoutcomesofanticoagulatedgeriatrictraumapatientswithtraumaticintracranialhemorrhageafterfalls
AT vanwijcksuzannefm treatmentandoutcomesofanticoagulatedgeriatrictraumapatientswithtraumaticintracranialhemorrhageafterfalls
AT krijnenpieta treatmentandoutcomesofanticoagulatedgeriatrictraumapatientswithtraumaticintracranialhemorrhageafterfalls
AT velmahosgeorgec treatmentandoutcomesofanticoagulatedgeriatrictraumapatientswithtraumaticintracranialhemorrhageafterfalls
AT kaafaranihaythamma treatmentandoutcomesofanticoagulatedgeriatrictraumapatientswithtraumaticintracranialhemorrhageafterfalls
AT rosenthalmarting treatmentandoutcomesofanticoagulatedgeriatrictraumapatientswithtraumaticintracranialhemorrhageafterfalls
AT schipperingerb treatmentandoutcomesofanticoagulatedgeriatrictraumapatientswithtraumaticintracranialhemorrhageafterfalls